1. Immunization Update 2007 Tdap Vaccine Segment
Satellite Broadcast/Webcast
August 9, 2007
Tdap Vaccine Segment
Graphics subject to change.
This material in the public domain.

2. Tdap Vaccines Boostrix (GlaxoSmithKline) Licensed May 2005 Single dose
Approved for persons 10 through 18 years of age
Adacel (sanofi pasteur)
Licensed June 2005
Approved for persons 11 through 64 years of age

3. General Principles for Use of Tdap and Td
No brand preference
Tdap preferred to Td to provide protection against pertussis
Approved only for a single booster dose in persons who have received a full series of pediatric DTaP or DTP

4. Use of Tdap Among Adults
Single dose of Tdap to replace a single dose of Td
Special emphasis on adults with close contact with infants (e.g., childcare and healthcare personnel, and parents)
Source: MMWR 2006;55(RR-17)

5. Persons Without a History of Pertussis Vaccination
All adolescents and adults should have documentation of having received a series of DTaP, DTP, DT, or Td
Persons without documentation should receive or complete a series of 3 doses
Preferred schedule:
single dose of Tdap
Td at least 4 weeks after the Tdap dose
second dose of Td at least 6 months after the prior Td dose
Source: MMWR 2006;55(RR-17)

6. Minimum Interval Between Td and Tdap
ACIP did not define an absolute minimum interval between Td and Tdap
Provider will need to decide based on whether the benefit of pertussis immunity outweighs the risk of a local adverse reaction
Source: MMWR 2006;55(RR-17)

7. Tdap and Pregnancy Td is generally preferred during pregnancy
All women should receive a dose of Tdap in the immediate postpartum period
Any woman who might become pregnant is encouraged to receive a single dose of Tdap
Source: MMWR 2006;55(RR-17)

8. Tdap and Pregnancy
A clinician may choose to administer Tdap to a pregnant woman in certain circumstances, such as during an outbreak of pertussis in the community
Pregnancy is not a contraindication to vaccination with Tdap
Source: MMWR 2006;55(RR-17)

9. Tdap and Healthcare Personnel (HCP)
HCP who work in hospitals or ambulatory care settings and have direct patient contact should receive a single dose of Tdap (Adacel only) as soon as feasible*
Priority should be given to vaccination of healthcare personnel who have direct contact with infants 12 months of age and younger
Other HCP should receive a single dose of Tdap to replace the next scheduled Td
*if they have not previously received Tdap.
MMWR 2006;55(RR-17)

10. Resource to Help Reduce DTaP/Tdap Administration Errors
“Check Your Vials” poster showing images of DTaP/Tdap/Td vials and packaging
Developed by the California Immunization Branch
Free download from

11. Website www.cdc.gov/nip
CDC Vaccines and Immunization Contact Information
Hotline (800) CDC-INFO
Website
Broadcast Updates and Resources
Web Page